Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Wolfgang Rödl"'
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1943
Nucleic acid-based therapies offer the option to treat tumors in a highly selective way, while toxicity towards healthy tissue can be avoided when proper delivery vehicles are used. We have recently developed carrier systems based on linear polyethyl
Publikováno v:
Nanotechnology for Nucleic Acid Delivery ISBN: 9781493990917
Nanotechnology for Nucleic Acid Delivery ISBN: 9781627031394
Nanotechnology for Nucleic Acid Delivery ISBN: 9781627031394
Nucleic acid-based therapies offer the option to treat tumors in a highly selective way, while toxicity towards healthy tissue can be avoided when proper delivery vehicles are used. We have recently developed carrier systems based on linear polyethyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519afd5764a46565e333c94255d7b859
https://doi.org/10.1007/978-1-4939-9092-4_6
https://doi.org/10.1007/978-1-4939-9092-4_6
Autor:
Koldo Urbiola, Laura Blanco-Fernandez, Ernst Wagner, Wolfgang Rödl, Conchita Tros de Ilarduya, Manfred Ogris
Publikováno v:
Journal of Personalized Medicine; Volume 8; Issue 1; Pages: 4
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 8, Iss 1, p 4 (2018)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 8, Iss 1, p 4 (2018)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
The transferrin (TfR) and epidermal growth factor receptors (EGFR) are known to be overexpressed on the surface of a wide variety of tumor cells. Therefore, the peptides B6 (TfR specific) and GE11 (targeted to the EGFR) were linked to the PAMAM (poly
Publikováno v:
The Journal of Gene Medicine. 17:161-172
Background Transferrin receptor (TfR), over-expressed on a majority of malignant cells, has been widely studied as a target for drug, protein and gene delivery. Both stable nucleic acid compact ability and efficient cytosol gene release capability ar
Publikováno v:
Molecular pharmaceutics. 14(5)
The specific transport of bioactive proteins into designated target cells is an interesting and challenging perspective for the generation of innovative biopharmaceuticals. Natural protein cytotoxins perform this task with outstanding efficacy. They
Autor:
Andrea M. Müller, Nathalie Schwenk, Christina Schug, Christine Spitzweg, Wolfgang Rödl, Ernst Wagner, Sarah Urnauer, Stephan Morys, Dirk-André Clevert, Peter Bartenstein, Kathrin A Schmohl, Mariella Tutter, Jens Bertram, Michael Ingrisch
Publikováno v:
Oncotarget
// Sarah Urnauer 1 , Andrea M. Muller 1 , Christina Schug 1 , Kathrin A. Schmohl 1 , Mariella Tutter 1 , Nathalie Schwenk 1 , Wolfgang Rodl 2 , Stephan Morys 2 , Michael Ingrisch 3 , Jens Bertram 4 , Peter Bartenstein 5 , Dirk-Andre Clevert 3 , Ernst
Autor:
Franz-Josef Gildehaus, Stephan Morys, Nathalie Schwenk, Kathrin Klutz, Geoffrey K. Grünwald, Christian Zach, Sarah Urnauer, Christine Spitzweg, Ernst Wagner, Wolfgang Rödl, Manfred Ogris
Publikováno v:
The journal of gene medicine. 19(5)
Background Non-viral polymer-based gene transfer represents an adaptable system for tumor-targeted gene therapy, as various design strategies of shuttle systems together with the mechanistic concept of active tumor targeting lead to improved gene del
Autor:
Alexandra Vetter, Sigrid Espenlaub, Per Sonne Holm, Wolfgang Rödl, Christina Scheu, Kulpreet Singh Virdi, Florian Kreppel, Manfred Ogris, Christine Spitzweg, Ernst Wagner
Publikováno v:
Molecular Pharmaceutics. 10:606-618
Adenovirus type 5 (Ad) is an efficient gene vector with high gene transduction potential, but its efficiency depends on its native cell receptors coxsackie- and adenovirus receptor (CAR) for cell attachment and α(v)β(3/5) integrins for internalizat
Autor:
Wolfgang Rödl, Eva Kessel, Wei Zhang, Katharina Müller, Ernst Wagner, Sören Reinhard, Philipp M. Klein, Dongsheng He, Susanne Kempter, Miriam Höhn
Publikováno v:
Advanced healthcare materials. 5(12)
Developing RNA-interference-based therapeutic approaches with efficient and targeted cytosolic delivery of small interfering RNA (siRNA) is remaining a critical challenge since two decades. Herein, a multifunctional transferrin receptor (TfR)-targete
Publikováno v:
Journal of Controlled Release. 159:92-103
The non-viral delivery of nucleic acids faces many extracellular and intracellular hurdles on the way from injection site to the site of action. Among these, aggregation in the blood stream and rapid elimination by the mononuclear phagocytic system (